Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Acute myeloid leukemia
| Copanlisib | 121 [1] 121 💬1. Acute myeloid leukemia
|
||||||||||||||
| 2 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬AGE-RAGE signaling pathway in diabetic complications
| Copanlisib | 121 [1] 121 💬2. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||
| 3 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 34 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Aldosterone-regulated sodium reabsorption
| Copanlisib | 121 [1] 121 💬3. Aldosterone-regulated sodium reabsorption
|
||||||||||||||
| 4 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Alzheimer disease
| Copanlisib | 121 [1] 121 💬4. Alzheimer disease
|
||||||||||||||
| 5 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 77 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Amoebiasis
| Copanlisib | 121 [1] 121 💬5. Amoebiasis
|
||||||||||||||
| 6 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬AMPK signaling pathway
| Copanlisib | 121 [1] 121 💬6. AMPK signaling pathway
|
||||||||||||||
| 7 | Apoptosis 💬 18 genes, 32 drugs (DrugBank) and 68 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Apoptosis
| Copanlisib | 121 [1] 121 💬7. Apoptosis
|
||||||||||||||
| 8 | Autophagy - animal 💬 14 genes, 21 drugs (DrugBank) and 71 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Autophagy - animal
| Copanlisib | 121 [1] 121 💬8. Autophagy - animal
|
||||||||||||||
| 9 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 73 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Axon guidance
| Copanlisib | 121 [1] 121 💬9. Axon guidance
|
||||||||||||||
| 10 | B cell receptor signaling pathway 💬 19 genes, 38 drugs (DrugBank) and 68 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬B cell receptor signaling pathway
| Copanlisib | 121 [1] 121 💬10. B cell receptor signaling pathway
|
||||||||||||||
| 11 | Bacterial invasion of epithelial cells 💬 7 genes, 10 drugs (DrugBank) and 24 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Bacterial invasion of epithelial cells
| Copanlisib | 121 [1] 121 💬11. Bacterial invasion of epithelial cells
|
||||||||||||||
| 12 | Breast cancer 💬 22 genes, 64 drugs (DrugBank) and 84 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Breast cancer
| Copanlisib | 121 [1] 121 💬12. Breast cancer
|
||||||||||||||
| 13 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬C-type lectin receptor signaling pathway
| Copanlisib | 121 [1] 121 💬13. C-type lectin receptor signaling pathway
|
||||||||||||||
| 14 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬cAMP signaling pathway
| Copanlisib | 121 [1] 121 💬14. cAMP signaling pathway
|
||||||||||||||
| 15 | Carbohydrate digestion and absorption 💬 13 genes, 22 drugs (DrugBank) and 40 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Carbohydrate digestion and absorption
| Copanlisib | 121 [1] 121 💬15. Carbohydrate digestion and absorption
|
||||||||||||||
| 16 | Cellular senescence 💬 35 genes, 48 drugs (DrugBank) and 97 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Cellular senescence
| Copanlisib | 121 [1] 121 💬16. Cellular senescence
|
||||||||||||||
| 17 | Central carbon metabolism in cancer 💬 20 genes, 37 drugs (DrugBank) and 70 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Central carbon metabolism in cancer
| Copanlisib | 121 [1] 121 💬17. Central carbon metabolism in cancer
|
||||||||||||||
| 18 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chagas disease
| Copanlisib | 121 [1] 121 💬18. Chagas disease
|
||||||||||||||
| 19 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chemical carcinogenesis - reactive oxygen species
| Copanlisib | 121 [1] 121 💬19. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||
| 20 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chemical carcinogenesis - receptor activation
| Copanlisib | 121 [1] 121 💬20. Chemical carcinogenesis - receptor activation
|
||||||||||||||
| 21 | Chemokine signaling pathway 💬 25 genes, 38 drugs (DrugBank) and 66 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chemokine signaling pathway
| Copanlisib | 121 [1] 121 💬21. Chemokine signaling pathway
|
||||||||||||||
| 22 | Choline metabolism in cancer 💬 11 genes, 29 drugs (DrugBank) and 64 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Choline metabolism in cancer
| Copanlisib | 121 [1] 121 💬22. Choline metabolism in cancer
|
||||||||||||||
| 23 | Cholinergic synapse 💬 32 genes, 65 drugs (DrugBank) and 87 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Cholinergic synapse
| Copanlisib | 121 [1] 121 💬23. Cholinergic synapse
|
||||||||||||||
| 24 | Chronic myeloid leukemia 💬 18 genes, 23 drugs (DrugBank) and 39 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chronic myeloid leukemia
| Copanlisib | 121 [1] 121 💬24. Chronic myeloid leukemia
|
||||||||||||||
| 25 | Colorectal cancer 💬 15 genes, 27 drugs (DrugBank) and 62 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Colorectal cancer
| Copanlisib | 121 [1] 121 💬25. Colorectal cancer
|
||||||||||||||
| 26 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Coronavirus disease
| Copanlisib | 121 [1] 121 💬26. Coronavirus disease
|
||||||||||||||
| 27 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Diabetic cardiomyopathy
| Copanlisib | 121 [1] 121 💬27. Diabetic cardiomyopathy
|
||||||||||||||
| 28 | Endometrial cancer 💬 10 genes, 19 drugs (DrugBank) and 28 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Endometrial cancer
| Copanlisib | 121 [1] 121 💬28. Endometrial cancer
|
||||||||||||||
| 29 | Epstein-Barr virus infection 💬 67 genes, 97 drugs (DrugBank) and 83 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Epstein-Barr virus infection
| Copanlisib | 121 [1] 121 💬29. Epstein-Barr virus infection
|
||||||||||||||
| 30 | ErbB signaling pathway 💬 14 genes, 27 drugs (DrugBank) and 65 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬ErbB signaling pathway
| Copanlisib | 121 [1] 121 💬30. ErbB signaling pathway
|
||||||||||||||
| 31 | Estrogen signaling pathway 💬 20 genes, 80 drugs (DrugBank) and 70 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Estrogen signaling pathway
| Copanlisib | 121 [1] 121 💬31. Estrogen signaling pathway
|
||||||||||||||
| 32 | Fc epsilon RI signaling pathway 💬 19 genes, 49 drugs (DrugBank) and 71 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Fc epsilon RI signaling pathway
| Copanlisib | 121 [1] 121 💬32. Fc epsilon RI signaling pathway
|
||||||||||||||
| 33 | Fc gamma R-mediated phagosome formation 💬 9 genes, 13 drugs (DrugBank) and 20 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Fc gamma R-mediated phagosome formation
| Copanlisib | 121 [1] 121 💬33. Fc gamma R-mediated phagosome formation
|
||||||||||||||
| 34 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Fluid shear stress and atherosclerosis
| Copanlisib | 121 [1] 121 💬34. Fluid shear stress and atherosclerosis
|
||||||||||||||
| 35 | Focal adhesion 💬 31 genes, 52 drugs (DrugBank) and 54 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Focal adhesion
| Copanlisib | 121 [1] 121 💬35. Focal adhesion
|
||||||||||||||
| 36 | FoxO signaling pathway 💬 26 genes, 43 drugs (DrugBank) and 62 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬FoxO signaling pathway
| Copanlisib | 121 [1] 121 💬36. FoxO signaling pathway
|
||||||||||||||
| 37 | Gastric cancer 💬 23 genes, 41 drugs (DrugBank) and 69 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Gastric cancer
| Copanlisib | 121 [1] 121 💬37. Gastric cancer
|
||||||||||||||
| 38 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 67 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Glioma
| Copanlisib | 121 [1] 121 💬38. Glioma
|
||||||||||||||
| 39 | GnRH secretion 💬 27 genes, 49 drugs (DrugBank) and 62 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬GnRH secretion
| Copanlisib | 121 [1] 121 💬39. GnRH secretion
|
||||||||||||||
| 40 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Growth hormone synthesis, secretion and action
| Copanlisib | 121 [1] 121 💬40. Growth hormone synthesis, secretion and action
|
||||||||||||||
| 41 | Hepatitis B 💬 44 genes, 70 drugs (DrugBank) and 92 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hepatitis B
| Copanlisib | 121 [1] 121 💬41. Hepatitis B
|
||||||||||||||
| 42 | Hepatitis C 💬 37 genes, 75 drugs (DrugBank) and 92 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hepatitis C
| Copanlisib | 121 [1] 121 💬42. Hepatitis C
|
||||||||||||||
| 43 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hepatocellular carcinoma
| Copanlisib | 121 [1] 121 💬43. Hepatocellular carcinoma
|
||||||||||||||
| 44 | Herpes simplex virus 1 infection 💬 71 genes, 85 drugs (DrugBank) and 110 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Herpes simplex virus 1 infection
| Copanlisib | 121 [1] 121 💬44. Herpes simplex virus 1 infection
|
||||||||||||||
| 45 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬HIF-1 signaling pathway
| Copanlisib | 121 [1] 121 💬45. HIF-1 signaling pathway
|
||||||||||||||
| 46 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hormone signaling
| Copanlisib | 121 [1] 121 💬46. Hormone signaling
|
||||||||||||||
| 47 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human cytomegalovirus infection
| Copanlisib | 121 [1] 121 💬47. Human cytomegalovirus infection
|
||||||||||||||
| 48 | Human immunodeficiency virus 1 infection 💬 51 genes, 59 drugs (DrugBank) and 98 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human immunodeficiency virus 1 infection
| Copanlisib | 121 [1] 121 💬48. Human immunodeficiency virus 1 infection
|
||||||||||||||
| 49 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human papillomavirus infection
| Copanlisib | 121 [1] 121 💬49. Human papillomavirus infection
|
||||||||||||||
| 50 | Human T-cell leukemia virus 1 infection 💬 61 genes, 80 drugs (DrugBank) and 105 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human T-cell leukemia virus 1 infection
| Copanlisib | 121 [1] 121 💬50. Human T-cell leukemia virus 1 infection
|
||||||||||||||
| 51 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬IgSF CAM signaling
| Copanlisib | 121 [1] 121 💬51. IgSF CAM signaling
|
||||||||||||||
| 52 | Inflammatory mediator regulation of TRP channels 💬 26 genes, 55 drugs (DrugBank) and 70 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Inflammatory mediator regulation of TRP channels
| Copanlisib | 121 [1] 121 💬52. Inflammatory mediator regulation of TRP channels
|
||||||||||||||
| 53 | Influenza A 💬 67 genes, 84 drugs (DrugBank) and 101 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Influenza A
| Copanlisib | 121 [1] 121 💬53. Influenza A
|
||||||||||||||
| 54 | Inositol phosphate metabolism 💬 4 genes, 5 drugs (DrugBank) and 10 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Inositol phosphate metabolism
| Copanlisib | 121 [1] 121 💬54. Inositol phosphate metabolism
|
||||||||||||||
| 55 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 104 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Insulin resistance
| Copanlisib | 121 [1] 121 💬55. Insulin resistance
|
||||||||||||||
| 56 | Insulin signaling pathway 💬 13 genes, 28 drugs (DrugBank) and 74 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Insulin signaling pathway
| Copanlisib | 121 [1] 121 💬56. Insulin signaling pathway
|
||||||||||||||
| 57 | Integrin signaling 💬 28 genes, 48 drugs (DrugBank) and 77 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Integrin signaling
| Copanlisib | 121 [1] 121 💬57. Integrin signaling
|
||||||||||||||
| 58 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬JAK-STAT signaling pathway
| Copanlisib | 121 [1] 121 💬58. JAK-STAT signaling pathway
|
||||||||||||||
| 59 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Kaposi sarcoma-associated herpesvirus infection
| Copanlisib | 121 [1] 121 💬59. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||
| 60 | Leukocyte transendothelial migration 💬 19 genes, 23 drugs (DrugBank) and 37 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Leukocyte transendothelial migration
| Copanlisib | 121 [1] 121 💬60. Leukocyte transendothelial migration
|
||||||||||||||
| 61 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Lipid and atherosclerosis
| Copanlisib | 121 [1] 121 💬61. Lipid and atherosclerosis
|
||||||||||||||
| 62 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Longevity regulating pathway
| Copanlisib | 121 [1] 121 💬62. Longevity regulating pathway
|
||||||||||||||
| 63 | Longevity regulating pathway - multiple species 💬 11 genes, 18 drugs (DrugBank) and 70 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Longevity regulating pathway - multiple species
| Copanlisib | 121 [1] 121 💬63. Longevity regulating pathway - multiple species
|
||||||||||||||
| 64 | Measles 💬 42 genes, 72 drugs (DrugBank) and 70 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Measles
| Copanlisib | 121 [1] 121 💬64. Measles
|
||||||||||||||
| 65 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 45 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Melanoma
| Copanlisib | 121 [1] 121 💬65. Melanoma
|
||||||||||||||
| 66 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬MicroRNAs in cancer
| Copanlisib | 121 [1] 121 💬66. MicroRNAs in cancer
|
||||||||||||||
| 67 | mTOR signaling pathway 💬 15 genes, 33 drugs (DrugBank) and 99 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬mTOR signaling pathway
| Copanlisib | 121 [1] 121 💬67. mTOR signaling pathway
|
||||||||||||||
| 68 | Natural killer cell mediated cytotoxicity 💬 45 genes, 49 drugs (DrugBank) and 91 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Natural killer cell mediated cytotoxicity
| Copanlisib | 121 [1] 121 💬68. Natural killer cell mediated cytotoxicity
|
||||||||||||||
| 69 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
SLC6A2 [2] SLC6A2, SLC6A4 💬
|
Desipramine hydrochloride Desipramine hydrochloride 💬Neuroactive ligand signaling
| Desipramine | 121 [2] 121, 156 💬69. Neuroactive ligand signaling
|
||||||||||||||
| 70 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
SLC6A2 [2] SLC6A2, SLC6A4 💬
|
Desipramine Desipramine 💬Neuroactive ligand signaling
| Desipramine | 121 [2] 121, 156 💬69. Neuroactive ligand signaling
|
||||||||||||||
| 71 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 38 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Neurotrophin signaling pathway
| Copanlisib | 121 [1] 121 💬71. Neurotrophin signaling pathway
|
||||||||||||||
| 72 | Neutrophil extracellular trap formation 💬 37 genes, 45 drugs (DrugBank) and 78 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Neutrophil extracellular trap formation
| Copanlisib | 121 [1] 121 💬72. Neutrophil extracellular trap formation
|
||||||||||||||
| 73 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Non-alcoholic fatty liver disease
| Copanlisib | 121 [1] 121 💬73. Non-alcoholic fatty liver disease
|
||||||||||||||
| 74 | Non-small cell lung cancer 💬 21 genes, 39 drugs (DrugBank) and 57 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Non-small cell lung cancer
| Copanlisib | 121 [1] 121 💬74. Non-small cell lung cancer
|
||||||||||||||
| 75 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Osteoclast differentiation
| Copanlisib | 121 [1] 121 💬75. Osteoclast differentiation
|
||||||||||||||
| 76 | Pancreatic cancer 💬 20 genes, 43 drugs (DrugBank) and 86 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Pancreatic cancer
| Copanlisib | 121 [1] 121 💬76. Pancreatic cancer
|
||||||||||||||
| 77 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Pathways in cancer
| Copanlisib | 121 [1] 121 💬77. Pathways in cancer
|
||||||||||||||
| 78 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 70 drugs (DrugBank) and 104 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Copanlisib | 121 [1] 121 💬78. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||
| 79 | Phagocytosis 💬 44 genes, 34 drugs (DrugBank) and 43 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Phagocytosis
| Copanlisib | 121 [1] 121 💬79. Phagocytosis
|
||||||||||||||
| 80 | Phosphatidylinositol signaling system 💬 5 genes, 6 drugs (DrugBank) and 11 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Phosphatidylinositol signaling system
| Copanlisib | 121 [1] 121 💬80. Phosphatidylinositol signaling system
|
||||||||||||||
| 81 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Phospholipase D signaling pathway
| Copanlisib | 121 [1] 121 💬81. Phospholipase D signaling pathway
|
||||||||||||||
| 82 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬PI3K-Akt signaling pathway
| Copanlisib | 121 [1] 121 💬82. PI3K-Akt signaling pathway
|
||||||||||||||
| 83 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Platelet activation
| Copanlisib | 121 [1] 121 💬83. Platelet activation
|
||||||||||||||
| 84 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Prion disease
| Copanlisib | 121 [1] 121 💬84. Prion disease
|
||||||||||||||
| 85 | Progesterone-mediated oocyte maturation 💬 14 genes, 39 drugs (DrugBank) and 47 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Progesterone-mediated oocyte maturation
| Copanlisib | 121 [1] 121 💬85. Progesterone-mediated oocyte maturation
|
||||||||||||||
| 86 | Prolactin signaling pathway 💬 20 genes, 44 drugs (DrugBank) and 74 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Prolactin signaling pathway
| Copanlisib | 121 [1] 121 💬86. Prolactin signaling pathway
|
||||||||||||||
| 87 | Prostate cancer 💬 24 genes, 58 drugs (DrugBank) and 92 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Prostate cancer
| Copanlisib | 121 [1] 121 💬87. Prostate cancer
|
||||||||||||||
| 88 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Proteoglycans in cancer
| Copanlisib | 121 [1] 121 💬88. Proteoglycans in cancer
|
||||||||||||||
| 89 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Rap1 signaling pathway
| Copanlisib | 121 [1] 121 💬89. Rap1 signaling pathway
|
||||||||||||||
| 90 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Ras signaling pathway
| Copanlisib | 121 [1] 121 💬90. Ras signaling pathway
|
||||||||||||||
| 91 | Regulation of actin cytoskeleton 💬 37 genes, 82 drugs (DrugBank) and 79 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Regulation of actin cytoskeleton
| Copanlisib | 121 [1] 121 💬91. Regulation of actin cytoskeleton
|
||||||||||||||
| 92 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Regulation of lipolysis in adipocytes
| Copanlisib | 121 [1] 121 💬92. Regulation of lipolysis in adipocytes
|
||||||||||||||
| 93 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Relaxin signaling pathway
| Copanlisib | 121 [1] 121 💬93. Relaxin signaling pathway
|
||||||||||||||
| 94 | Renal cell carcinoma 💬 15 genes, 16 drugs (DrugBank) and 32 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Renal cell carcinoma
| Copanlisib | 121 [1] 121 💬94. Renal cell carcinoma
|
||||||||||||||
| 95 | Salmonella infection 💬 32 genes, 48 drugs (DrugBank) and 78 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Salmonella infection
| Copanlisib | 121 [1] 121 💬95. Salmonella infection
|
||||||||||||||
| 96 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
SLC6A4 [1] SLC6A4 💬Serotonergic synapse
|
Desipramine hydrochloride Desipramine hydrochloride 💬Serotonergic synapse
| Desipramine | 121 [2] 121, 156 💬96. Serotonergic synapse
|
||||||||||||||
| 97 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
SLC6A4 [1] SLC6A4 💬Serotonergic synapse
|
Desipramine Desipramine 💬Serotonergic synapse
| Desipramine | 121 [2] 121, 156 💬96. Serotonergic synapse
|
||||||||||||||
| 98 | Shigellosis 💬 31 genes, 54 drugs (DrugBank) and 97 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Shigellosis
| Copanlisib | 121 [1] 121 💬98. Shigellosis
|
||||||||||||||
| 99 | Signaling pathways regulating pluripotency of stem cells 💬 21 genes, 39 drugs (DrugBank) and 64 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Signaling pathways regulating pluripotency of stem cells
| Copanlisib | 121 [1] 121 💬99. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||
| 100 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Small cell lung cancer
| Copanlisib | 121 [1] 121 💬100. Small cell lung cancer
|
||||||||||||||
| 101 | Sphingolipid signaling pathway 💬 32 genes, 56 drugs (DrugBank) and 84 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Sphingolipid signaling pathway
| Copanlisib | 121 [1] 121 💬101. Sphingolipid signaling pathway
|
||||||||||||||
| 102 | Spinocerebellar ataxia 💬 18 genes, 30 drugs (DrugBank) and 79 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Spinocerebellar ataxia
| Copanlisib | 121 [1] 121 💬102. Spinocerebellar ataxia
|
||||||||||||||
| 103 | Synaptic vesicle cycle 💬 8 genes, 32 drugs (DrugBank) and 43 diseases |
SLC6A2 [2] SLC6A2, SLC6A4 💬
|
Desipramine hydrochloride Desipramine hydrochloride 💬Synaptic vesicle cycle
| Desipramine | 121 [2] 121, 156 💬103. Synaptic vesicle cycle
|
||||||||||||||
| 104 | Synaptic vesicle cycle 💬 8 genes, 32 drugs (DrugBank) and 43 diseases |
SLC6A2 [2] SLC6A2, SLC6A4 💬
|
Desipramine Desipramine 💬Synaptic vesicle cycle
| Desipramine | 121 [2] 121, 156 💬103. Synaptic vesicle cycle
|
||||||||||||||
| 105 | T cell receptor signaling pathway 💬 35 genes, 58 drugs (DrugBank) and 88 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬T cell receptor signaling pathway
| Copanlisib | 121 [1] 121 💬105. T cell receptor signaling pathway
|
||||||||||||||
| 106 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Thyroid hormone signaling pathway
| Copanlisib | 121 [1] 121 💬106. Thyroid hormone signaling pathway
|
||||||||||||||
| 107 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬TNF signaling pathway
| Copanlisib | 121 [1] 121 💬107. TNF signaling pathway
|
||||||||||||||
| 108 | Toll-like receptor signaling pathway 💬 41 genes, 68 drugs (DrugBank) and 84 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Toll-like receptor signaling pathway
| Copanlisib | 121 [1] 121 💬108. Toll-like receptor signaling pathway
|
||||||||||||||
| 109 | Type II diabetes mellitus 💬 15 genes, 44 drugs (DrugBank) and 100 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Type II diabetes mellitus
| Copanlisib | 121 [1] 121 💬109. Type II diabetes mellitus
|
||||||||||||||
| 110 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬VEGF signaling pathway
| Copanlisib | 121 [1] 121 💬110. VEGF signaling pathway
|
||||||||||||||
| 111 | Viral carcinogenesis 💬 32 genes, 34 drugs (DrugBank) and 60 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Viral carcinogenesis
| Copanlisib | 121 [1] 121 💬111. Viral carcinogenesis
|
||||||||||||||
| 112 | Yersinia infection 💬 25 genes, 43 drugs (DrugBank) and 78 diseases |
PIK3CA [2] PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Yersinia infection
| Copanlisib | 121 [1] 121 💬112. Yersinia infection
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 58 drugs (DrugBank) and 100 diseases
Aldosterone-regulated sodium reabsorption
13 genes, 17 drugs (DrugBank) and 34 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
Amoebiasis
20 genes, 32 drugs (DrugBank) and 77 diseases
AMPK signaling pathway
16 genes, 58 drugs (DrugBank) and 100 diseases
Apoptosis
18 genes, 32 drugs (DrugBank) and 68 diseases
Autophagy - animal
14 genes, 21 drugs (DrugBank) and 71 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 73 diseases
B cell receptor signaling pathway
19 genes, 38 drugs (DrugBank) and 68 diseases
Bacterial invasion of epithelial cells
7 genes, 10 drugs (DrugBank) and 24 diseases
Breast cancer
22 genes, 64 drugs (DrugBank) and 84 diseases
C-type lectin receptor signaling pathway
28 genes, 71 drugs (DrugBank) and 108 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
Carbohydrate digestion and absorption
13 genes, 22 drugs (DrugBank) and 40 diseases
Cellular senescence
35 genes, 48 drugs (DrugBank) and 97 diseases
Central carbon metabolism in cancer
20 genes, 37 drugs (DrugBank) and 70 diseases
Chagas disease
32 genes, 59 drugs (DrugBank) and 88 diseases
Chemical carcinogenesis - reactive oxygen species
24 genes, 37 drugs (DrugBank) and 53 diseases
Chemical carcinogenesis - receptor activation
41 genes, 140 drugs (DrugBank) and 133 diseases
Chemokine signaling pathway
25 genes, 38 drugs (DrugBank) and 66 diseases
Choline metabolism in cancer
11 genes, 29 drugs (DrugBank) and 64 diseases
Cholinergic synapse
32 genes, 65 drugs (DrugBank) and 87 diseases
Chronic myeloid leukemia
18 genes, 23 drugs (DrugBank) and 39 diseases
Colorectal cancer
15 genes, 27 drugs (DrugBank) and 62 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Diabetic cardiomyopathy
25 genes, 48 drugs (DrugBank) and 80 diseases
Endometrial cancer
10 genes, 19 drugs (DrugBank) and 28 diseases
Epstein-Barr virus infection
67 genes, 97 drugs (DrugBank) and 83 diseases
ErbB signaling pathway
14 genes, 27 drugs (DrugBank) and 65 diseases
Estrogen signaling pathway
20 genes, 80 drugs (DrugBank) and 70 diseases
Fc epsilon RI signaling pathway
19 genes, 49 drugs (DrugBank) and 71 diseases
Fc gamma R-mediated phagosome formation
9 genes, 13 drugs (DrugBank) and 20 diseases
Fluid shear stress and atherosclerosis
33 genes, 60 drugs (DrugBank) and 100 diseases
Focal adhesion
31 genes, 52 drugs (DrugBank) and 54 diseases
FoxO signaling pathway
26 genes, 43 drugs (DrugBank) and 62 diseases
Gastric cancer
23 genes, 41 drugs (DrugBank) and 69 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 67 diseases
GnRH secretion
27 genes, 49 drugs (DrugBank) and 62 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 97 diseases
Hepatitis B
44 genes, 70 drugs (DrugBank) and 92 diseases
Hepatitis C
37 genes, 75 drugs (DrugBank) and 92 diseases
Hepatocellular carcinoma
22 genes, 33 drugs (DrugBank) and 70 diseases
Herpes simplex virus 1 infection
71 genes, 85 drugs (DrugBank) and 110 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Human cytomegalovirus infection
65 genes, 121 drugs (DrugBank) and 136 diseases
Human immunodeficiency virus 1 infection
51 genes, 59 drugs (DrugBank) and 98 diseases
Human papillomavirus infection
52 genes, 114 drugs (DrugBank) and 121 diseases
Human T-cell leukemia virus 1 infection
61 genes, 80 drugs (DrugBank) and 105 diseases
IgSF CAM signaling
45 genes, 68 drugs (DrugBank) and 91 diseases
Inflammatory mediator regulation of TRP channels
26 genes, 55 drugs (DrugBank) and 70 diseases
Influenza A
67 genes, 84 drugs (DrugBank) and 101 diseases
Inositol phosphate metabolism
4 genes, 5 drugs (DrugBank) and 10 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 104 diseases
Insulin signaling pathway
13 genes, 28 drugs (DrugBank) and 74 diseases
Integrin signaling
28 genes, 48 drugs (DrugBank) and 77 diseases
JAK-STAT signaling pathway
60 genes, 117 drugs (DrugBank) and 116 diseases
Kaposi sarcoma-associated herpesvirus infection
61 genes, 102 drugs (DrugBank) and 124 diseases
Leukocyte transendothelial migration
19 genes, 23 drugs (DrugBank) and 37 diseases
Lipid and atherosclerosis
52 genes, 73 drugs (DrugBank) and 107 diseases
Longevity regulating pathway
11 genes, 23 drugs (DrugBank) and 73 diseases
Longevity regulating pathway - multiple species
11 genes, 18 drugs (DrugBank) and 70 diseases
Measles
42 genes, 72 drugs (DrugBank) and 70 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 45 diseases
MicroRNAs in cancer
32 genes, 78 drugs (DrugBank) and 96 diseases
mTOR signaling pathway
15 genes, 33 drugs (DrugBank) and 99 diseases
Natural killer cell mediated cytotoxicity
45 genes, 49 drugs (DrugBank) and 91 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neurotrophin signaling pathway
22 genes, 29 drugs (DrugBank) and 38 diseases
Neutrophil extracellular trap formation
37 genes, 45 drugs (DrugBank) and 78 diseases
Non-alcoholic fatty liver disease
24 genes, 54 drugs (DrugBank) and 100 diseases
Non-small cell lung cancer
21 genes, 39 drugs (DrugBank) and 57 diseases
Osteoclast differentiation
40 genes, 93 drugs (DrugBank) and 109 diseases
Pancreatic cancer
20 genes, 43 drugs (DrugBank) and 86 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
34 genes, 70 drugs (DrugBank) and 104 diseases
Phagocytosis
44 genes, 34 drugs (DrugBank) and 43 diseases
Phosphatidylinositol signaling system
5 genes, 6 drugs (DrugBank) and 11 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
PI3K-Akt signaling pathway
86 genes, 147 drugs (DrugBank) and 129 diseases
Platelet activation
24 genes, 72 drugs (DrugBank) and 66 diseases
Prion disease
41 genes, 77 drugs (DrugBank) and 121 diseases
Progesterone-mediated oocyte maturation
14 genes, 39 drugs (DrugBank) and 47 diseases
Prolactin signaling pathway
20 genes, 44 drugs (DrugBank) and 74 diseases
Prostate cancer
24 genes, 58 drugs (DrugBank) and 92 diseases
Proteoglycans in cancer
34 genes, 75 drugs (DrugBank) and 107 diseases
Rap1 signaling pathway
47 genes, 115 drugs (DrugBank) and 101 diseases
Ras signaling pathway
38 genes, 65 drugs (DrugBank) and 77 diseases
Regulation of actin cytoskeleton
37 genes, 82 drugs (DrugBank) and 79 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 53 diseases
Renal cell carcinoma
15 genes, 16 drugs (DrugBank) and 32 diseases
Salmonella infection
32 genes, 48 drugs (DrugBank) and 78 diseases
Serotonergic synapse
40 genes, 130 drugs (DrugBank) and 89 diseases
Shigellosis
31 genes, 54 drugs (DrugBank) and 97 diseases
Signaling pathways regulating pluripotency of stem cells
21 genes, 39 drugs (DrugBank) and 64 diseases
Small cell lung cancer
15 genes, 47 drugs (DrugBank) and 63 diseases
Sphingolipid signaling pathway
32 genes, 56 drugs (DrugBank) and 84 diseases
Spinocerebellar ataxia
18 genes, 30 drugs (DrugBank) and 79 diseases
Synaptic vesicle cycle
8 genes, 32 drugs (DrugBank) and 43 diseases
T cell receptor signaling pathway
35 genes, 58 drugs (DrugBank) and 88 diseases
Thyroid hormone signaling pathway
25 genes, 46 drugs (DrugBank) and 78 diseases
TNF signaling pathway
25 genes, 64 drugs (DrugBank) and 95 diseases
Toll-like receptor signaling pathway
41 genes, 68 drugs (DrugBank) and 84 diseases
Type II diabetes mellitus
15 genes, 44 drugs (DrugBank) and 100 diseases
VEGF signaling pathway
22 genes, 58 drugs (DrugBank) and 94 diseases
Viral carcinogenesis
32 genes, 34 drugs (DrugBank) and 60 diseases
Yersinia infection
25 genes, 43 drugs (DrugBank) and 78 diseases
